timothy sykes logo
LFST Stock Slips As 35M-Share Secondary Tests Market Demand Thumbnail

LFST Stock Slips As 35M-Share Secondary Tests Market Demand

TIM SYKESUPDATED MAY. 8, 2026, 11:32 AM ET
Reviewed by Jack Kelloggand Fact-checked by Ellis Hobbs

LifeStance Health Group Inc. faces heightened investor concern over mental health demand trends as stocks have been trading down by -11.36 percent.

Candlestick Chart

Live Update At 11:32:06 EDT: On Friday, May 08, 2026 LifeStance Health Group Inc. stock [NASDAQ: LFST] is trending down by -11.36%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

LFST has been grinding higher over the last few weeks, and the tape shows it. From mid‑April closes near $6.40–$6.60, LifeStance Health Group Inc. has pushed up toward the high‑$7s and low‑$8s. The close at $7.85 on 2026/05/08 still sits below the $8.15 secondary offering price, but the trend is clearly up.

On a five‑minute chart, LFST trades in a tight intraday band between roughly $7.75 and $7.95, with repeated pushes into the low‑$7.90s getting sold. That tells traders there is real supply just under $8, exactly where the secondary and spot trading are colliding.

Fundamentally, LifeStance Health prints about $1.42B in annual revenue, growing at a double‑digit clip over three and five years. But margins are thin. The latest quarter shows EBITDA of $35.1M on $403.5M of revenue, and net income of just $14.2M. That’s how you end up with a sky‑high P/E near 368 and a price‑to‑sales ratio around 2.

Balance‑sheet strength is decent. LFST holds roughly $194.8M in cash, with total debt levels giving a modest 0.3 debt‑to‑equity and a current ratio of 1.7. For traders, this looks like a growth mental‑health platform with improving cash flow, but not much earnings cushion if sentiment cracks.

Why Traders Are Watching LFST’s Secondary Deal

LFST is front and center on many traders’ screens because of one thing: a massive 35 million‑share secondary offering by existing holders. LifeStance Health announced the deal with a price talk of $8.15–$8.50. Then they priced it at $8.15, the bottom of the range, with J.P. Morgan running the book.

When a deal prices at the low end, the message is simple. Big money was only willing to take LFST stock at a discount. That often creates near‑term pressure as those shares hit the market and short‑term flippers look to lock in small gains. For a name like LifeStance Health Group Inc., where average daily volume is already concentrated, 35 million extra shares is a serious wall of supply.

The twist is the concurrent buyback. LFST plans to repurchase 6 million shares from the underwriter at the same $8.15 price, as long as the secondary closes. That does two things. First, it signals LifeStance management still believes in the long‑term story and is willing to deploy cash. Second, it partially offsets the added float, though 6 million is still much smaller than 35 million.

Traders also notice the insider angle. Director Robert Bessler sold 69,899 LifeStance shares on 2026/04/23 for about $492,400, but he continues to hold about 1.49 million shares. That looks more like portfolio tuning than a full‑on exit. Still, combined with the secondary, it reinforces the theme of more LFST stock coming to market at current levels.

This tug‑of‑war—large holders cashing out while LFST itself buys back stock—is exactly the kind of supply‑demand setup active traders watch for quick momentum shifts.

More Breaking News

Conclusion

LFST sits at an important crossroads. On the chart, LifeStance Health Group Inc. has broken out from the mid‑$6s into the high‑$7s, with a recent spike to an $8.85 close on 2026/05/07 before pulling back to $7.85 the next day. That swing, right around the $8.15 secondary price, shows traders are already using the offering level as a reference line.

Under the hood, LifeStance is a high‑revenue, thin‑margin mental‑health platform with solid liquidity and manageable leverage. Cash flow from operations of $33.1M last quarter and free cash flow of $22.3M give LFST some room to support the stock, which ties directly into the 6 million‑share buyback tied to the secondary.

But the near‑term story is still about supply. Thirty‑five million shares from existing LFST holders, priced at the bottom of the range, usually means more choppy trading and potential weakness until the market absorbs the block. Short‑biased traders will watch for failed bounces near $8.15. Long‑biased traders will watch for strong holds above that level on heavy volume as a sign the overhang is being cleared.

As millionaire penny stock trader and teacher Tim Sykes, says, “Preparation plus patience leads to big profits.”. As Tim Sykes likes to say, “Patterns repeat because people repeat—if you study the past, you give yourself a real edge.” For LifeStance Health Group Inc., the pattern is a classic secondary‑overhang setup. Traders who track the price action around $8.15, respect their risk, and react to the real‑time tape—not the story—will be the ones best positioned to learn from how LFST trades this deal. This article is for educational and research purposes only and is not investment advice.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:



How much has this post helped you?


Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”